Form 4 Tracker
Natera, Inc.
NTRA

118 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 27, 2026Apr 30 1:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
5,838$204.14$1.2M150,769(D)

View →

Apr 27, 2026Apr 30 1:35 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
1,688$204.10$344.5K187,511(D)

View →

Apr 27, 2026Apr 30 1:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
2,182$204.10$445.3K145,700(D)

View →

Apr 27, 2026Apr 30 1:35 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
1,861$204.09$379.8K223,024(D)

View →

Apr 29, 2026Apr 30 1:35 AMJonathan SheenaDirector, Other
Sale
3,071$196.42$603.2K255,711(D)

View →

Apr 27, 2026Apr 30 1:35 AMJonathan SheenaDirector, Other
Sale
473$204.00$96.5K258,782(D)

View →

Apr 29, 2026Apr 29 8:35 PMMICHAEL BROPHY
Proposed Sale
3,070$200.17$614.5K

View →

Apr 17, 2026Apr 22 1:05 AMJonathan SheenaDirector, Other
Sale
1,500$199.63$299.4K20,282(I)

View →

Apr 1, 2026Apr 4 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
8,400$203.31$1.7M224,885(D)

View →

Apr 1, 2026Apr 4 1:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
3,000$202.30$606.9K147,882(D)

View →

Apr 1, 2026Apr 1 8:05 PMSOLOMON MOSHKEVICH
Proposed Sale
3,000$202.30$606.9K

View →

Mar 20, 2026Mar 21 1:05 AMJonathan SheenaDirector, Other
Sale
1,500$199.95$299.9K21,032(I)

View →

Mar 18, 2026Mar 21 1:05 AMJonathan SheenaDirector, Other
Sale
3,070$198.17$608.4K259,255(D)

View →

Mar 20, 2026Mar 20 5:07 PMSheena Jonathan
Proposed Sale
6,000$200.25$1.2M

View →

Mar 18, 2026Mar 18 3:19 PMSheena Jonathan
Proposed Sale
12,441$198.16$2.5M

View →

Mar 13, 2026Mar 18 1:05 AMRowan E ChapmanDirector
Sale
122$191.38$23.3K5,752(D)

View →

Mar 16, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
50,000$196.28$9.8M2,310,772(D)

View →

Mar 13, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
75,000$189.01$14.2M2,310,772(D)

View →

Mar 12, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
75,000$190.59$14.3M2,310,772(D)

View →

Mar 13, 2026Mar 13 8:19 PMROWAN EMMA CHAPMAN
Proposed Sale
122$191.38$23.3K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 10 1:05 AMGail Boxer MarcusDirector
Option Exercise
11,000$22.8311,000(D)

View →

Apr 6, 2026Apr 9 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
58,292$9.590(D)

View →

Mar 31, 2026Apr 2 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
41,708$9.5958,292(D)

View →

Mar 16, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$9.59100,000(D)

View →

Mar 13, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59150,000(D)

View →

Mar 12, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59225,000(D)

View →

Mar 6, 2026Mar 11 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
5,598$19.680(D)

View →

Mar 2, 2026Mar 4 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Option Exercise
5,125$9.590(D)

View →

Jan 20, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Option Exercise
3,3860(D)

View →

Jan 20, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Option Exercise
1,5220(D)

View →

Jan 20, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Option Exercise
1910(D)

View →

Jan 20, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
8560(D)

View →